Developing targeted therapies for soft tissue sarcoma
SPORE in Soft Tissue Sarcoma
['FUNDING_OTHER'] · SLOAN-KETTERING INST CAN RESEARCH · NIH-10848812
This study is looking for better ways to treat soft tissue sarcoma by focusing on the unique genetic changes in this cancer, and it will involve both adults and children to find out what works best.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | SLOAN-KETTERING INST CAN RESEARCH (nih funded) |
| Locations | 1 site (NEW YORK, UNITED STATES) |
| Trial ID | NIH-10848812 on ClinicalTrials.gov |
What this research studies
This research aims to reduce the impact of soft tissue sarcoma by creating therapies that target specific genetic and molecular changes associated with different types of this cancer. The team will investigate the underlying mechanisms that lead to sarcoma development and resistance to existing treatments. They will also validate new treatment targets through clinical trials involving both adults and children, utilizing a large database of patient outcomes and biological samples collected over decades.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with soft tissue sarcoma, both adults and children.
Not a fit: Patients with other types of cancer or those who do not have soft tissue sarcoma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized treatment options for patients with soft tissue sarcoma.
How similar studies have performed: Previous research has shown promise in developing targeted therapies for various cancers, indicating that this approach could be effective for soft tissue sarcoma as well.
Where this research is happening
NEW YORK, UNITED STATES
- SLOAN-KETTERING INST CAN RESEARCH — NEW YORK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SINGER, SAMUEL — SLOAN-KETTERING INST CAN RESEARCH
- Study coordinator: SINGER, SAMUEL
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Animal Cancer Model, Cancer Center Support Grant, Cancers